the market cap has nothing to do with anything. I was just trying to get across that medicare is only a piece of of the puzzle. MDVN has a great drug, dndn has an okay drug with no assay and horrible margins. all the medicare in the world won't save that stock. rosetta may or may not succeed, but it is a wait and see.
hard for me to see, that if it were such a great test, why was it not being used... why are insiders not buying... why why why...
does not mean I won't buy again if it startes to run, but this by no means a longterm investment. money to be made play it safe
News 
Market Data 
Discover 
AI
